NYSE$ITGR

Integer Holdings Corporation · Q2 2024 earnings

Q2 2024 earnings · · Investor relations

Briefing

Integer reported a strong second quarter with sales growth and increased adjusted operating income, leading to an improved full-year profit outlook.

Integer Holdings Corporation announced strong second-quarter results, featuring 9% sales growth and a 20% increase in adjusted operating income. The company raised its full-year adjusted operating income growth outlook to 14% to 21%, reflecting successful execution of its strategy.

  • Integer delivered strong quarter with 9% sales growth.
  • Adjusted operating income increased 20% versus a year ago.
  • The company expects 2024 above-market sales growth of 9% to 11%.
  • Full year adjusted operating income growth outlook raised to 14% to 21%.

Headline financials

Total Revenue

$436M

Previous: $400M+9.0%
EPS (adj)

$1.30

Previous: $1.14+14.0%
Capital Expenditures

-$60.3M

Previous: -$57.4M-4.9%
Free Cash Flow

-$29M

Previous: -$33.4M+13.3%
Net Income

$31.2M

Previous: $24M+30.3%
Operating Income

$55.2M

Previous: $41.6M+32.7%
Gross Profit

$119M

Previous: $106M+12.8%
Cash & Equivalents

$34.1M

Previous: $38.6M-11.6%
Total Assets

$3.13B

Previous: $2.86B+9.3%
R&D Expense

$16.1M

No prior period
Stock-Based Comp

$5.77M

Previous: $5.5M+4.8%

Revenue & EPS history

Integer · Revenue · Quarterly

$436M

Q2 2024+9%vs Q2 2023
Beat estimate in 10 of 15 quarters(67%)
ActualEstimate

Revenue by segment

Integer · $266M total across 2 segments · Q1 2023

  • Cardio & Vascular
    $149M
  • Cardiac Rhythm Management & Neuromodulation
    $117M

Forward guidance

Integer anticipates continued growth, projecting above-market sales growth and increased adjusted operating income for 2024. The company's outlook reflects confidence in its strategic execution and market position.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2024

Historical avgQ2 2024

-0.5%

Avg return

Earnings day

+0.4%

Avg return

5 days after

+2.4%

Avg return

30 days after

41%

25 / 61 earnings

Positive

+16.4%

Q3 2016

Best reaction

-33.2%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-0.3%+2.6%+6.8%
Q4 2025-3.4%+0.7%-2.8%
Q3 2025-33.2%-37.7%-35.8%
Q1 2025+0.8%+5.3%-1.8%
Q4 2024-5.6%-10.8%-19.6%
Q3 2024-0.6%+2.8%+9.2%
Q2 2024-6.2%-2.5%+1.7%
Q1 2024-11.1%-9.4%-0.5%
Q4 2023-5.4%-4.5%+8.3%
Q3 2023+13.6%+16.9%+29.0%
Q2 2023+5.5%+6.5%-5.4%
Q1 2023+1.3%+0.3%-1.2%
Q4 2022+6.0%+2.4%+1.4%
Q3 2022+4.2%+6.4%+20.0%
Q2 2022-0.5%-0.3%-5.2%
Q1 2022-5.1%-1.6%+1.7%
Q4 2021-2.2%-5.5%-7.2%
Q3 2021-1.6%-2.1%-9.0%
Q2 2021-0.9%-3.2%-0.5%
Q1 2021-2.1%-2.6%-5.7%
Q4 2020+9.6%+9.3%+15.5%
Q3 2020-4.1%-4.6%+19.3%
Q2 2020-6.0%-9.3%-0.1%
Q1 2020+6.3%+2.3%+19.0%
Q4 2019+4.9%+1.0%-45.2%
Q3 2019-1.1%-1.1%-2.3%
Q2 2019-3.7%-7.8%-17.3%
Q1 2019+10.7%+11.7%+3.5%
Q4 2018+0.7%+3.0%-1.3%
Q3 2018+13.1%+18.0%+18.9%
Q2 2018-0.9%+0.5%+11.9%
Q1 2018+13.0%+16.8%+17.6%
Q4 2017+16.0%+13.9%+24.6%
Q3 2017-2.7%-4.1%-2.2%
Q2 2017+2.7%+2.0%+0.4%
Q1 2017+2.5%+12.3%+13.9%
Q4 2016-0.7%+2.9%+7.0%
Q3 2016+16.4%+15.8%+51.9%
Q2 2016-30.4%-29.7%-26.5%
Q1 2016-10.4%
Q4 2015-14.3%
Q3 2015+6.4%
Q2 2015+4.0%
Q1 2015-3.5%
Q4 2014+1.0%
Q1 2014-4.0%
Q3 2014+6.8%
Q2 2014+2.9%
Q1 2013-5.1%
Q4 2012+0.1%
Q3 2012-0.5%
Q2 2012+1.3%
Q1 2011-1.4%
Q1 2012+0.6%
Q4 2011-2.8%
Q1 2010-2.8%
Q3 2010-3.6%
Q3 2011-3.6%
Q2 2011-0.8%
Q2 2010-0.8%
Q4 2010-0.8%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro